Report Detail

Pharma & Healthcare Global Type 1 Diabetes (T1D) Market Research Report 2019

  • RnM3122669
  • |
  • 14 March, 2019
  • |
  • Global
  • |
  • 104 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Type 1 diabetes (T1D) is an autoimmune disease that occurs when a person’s pancreas stops producing insulin, the hormone that controls blood-sugar levels. T1D develops when the insulin-producing pancreatic beta cells are mistakenly destroyed by the body’s immune system. The cause of this attack is still being researched, however scientists believe the cause may have genetic and environmental components.
Sedentary lifestyle, unhealthy diet, lack of exercise and increasing prevalence of diabetes are key driver for Type 1 Diabetes (T1D) market. Insulin therapy is very much essential in the patients who have type 1 diabetes. Rising launch of the novel insulin formulations along with several adjunct therapies will positively impact the insulin acceptance. On the other hand, this chronic disorder poses a significant economic impact owing to the increasing cost of insulin coupled with other conditions such as cardiac disorders, kidney disease among others. While insulin therapy keeps people with T1D alive and can help keep blood-glucose levels within recommended range, it is not a cure, nor does it prevent the possibility of T1D’s serious effects. Although T1D is a serious and challenging disease, long-term management options continue to evolve, allowing those with T1D to have full and active lives. Asia Pacific region recorded the highest growth rate over the forecast period owing to the increasingly sedentary lifestyles, obese population, and improper food habits. North America accounted for more than 50% of the total market share over the forecast period.

The global Type 1 Diabetes (T1D) market is valued at 1960 million US$ in 2018 is expected to reach 2810 million US$ by the end of 2025, growing at a CAGR of 4.6% during 2019-2025.
This report focuses on Type 1 Diabetes (T1D) volume and value at global level, regional level and company level. From a global perspective, this report represents overall Type 1 Diabetes (T1D) market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
Novo Nordisk
Sanofi
Eli Lilly
Merck
Boehringer Ingelheim
Samsung Bioepis
Biocon
Astellas
Janssen
Bristol-Myers Squibb
Lexicon
Sanofi

Segment by Regions
North America
Europe
China
Japan

Segment by Type
Rapid Acting Insulin Analogs
Long Acting Insulin Analogs
Premix Insulin Analogs

Segment by Application
Children
Adults


Table of Contents

    Executive Summary

      1 Type 1 Diabetes (T1D) Market Overview

      • 1.1 Product Overview and Scope of Type 1 Diabetes (T1D)
      • 1.2 Type 1 Diabetes (T1D) Segment by Type
        • 1.2.1 Global Type 1 Diabetes (T1D) Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 Rapid Acting Insulin Analogs
        • 1.2.3 Long Acting Insulin Analogs
        • 1.2.4 Premix Insulin Analogs
      • 1.3 Type 1 Diabetes (T1D) Segment by Application
        • 1.3.1 Type 1 Diabetes (T1D) Consumption Comparison by Application (2014-2025)
        • 1.3.2 Children
        • 1.3.3 Adults
      • 1.4 Global Type 1 Diabetes (T1D) Market by Region
        • 1.4.1 Global Type 1 Diabetes (T1D) Market Size Region
        • 1.4.2 North America Status and Prospect (2014-2025)
        • 1.4.3 Europe Status and Prospect (2014-2025)
        • 1.4.4 China Status and Prospect (2014-2025)
        • 1.4.5 Japan Status and Prospect (2014-2025)
      • 1.5 Global Type 1 Diabetes (T1D) Market Size
        • 1.5.1 Global Type 1 Diabetes (T1D) Revenue (2014-2025)
        • 1.5.2 Global Type 1 Diabetes (T1D) Production (2014-2025)

      2 Global Type 1 Diabetes (T1D) Market Competition by Manufacturers

      • 2.1 Global Type 1 Diabetes (T1D) Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Type 1 Diabetes (T1D) Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Type 1 Diabetes (T1D) Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Type 1 Diabetes (T1D) Production Sites, Area Served, Product Types
      • 2.5 Type 1 Diabetes (T1D) Market Competitive Situation and Trends
        • 2.5.1 Type 1 Diabetes (T1D) Market Concentration Rate
        • 2.5.2 Type 1 Diabetes (T1D) Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Type 1 Diabetes (T1D) Production Market Share by Regions

      • 3.1 Global Type 1 Diabetes (T1D) Production Market Share by Regions
      • 3.2 Global Type 1 Diabetes (T1D) Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Type 1 Diabetes (T1D) Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Type 1 Diabetes (T1D) Production
        • 3.4.1 North America Type 1 Diabetes (T1D) Production Growth Rate (2014-2019)
        • 3.4.2 North America Type 1 Diabetes (T1D) Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Type 1 Diabetes (T1D) Production
        • 3.5.1 Europe Type 1 Diabetes (T1D) Production Growth Rate (2014-2019)
        • 3.5.2 Europe Type 1 Diabetes (T1D) Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Type 1 Diabetes (T1D) Production (2014-2019)
        • 3.6.1 China Type 1 Diabetes (T1D) Production Growth Rate (2014-2019)
        • 3.6.2 China Type 1 Diabetes (T1D) Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Type 1 Diabetes (T1D) Production (2014-2019)
        • 3.7.1 Japan Type 1 Diabetes (T1D) Production Growth Rate (2014-2019)
        • 3.7.2 Japan Type 1 Diabetes (T1D) Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Type 1 Diabetes (T1D) Consumption by Regions

      • 4.1 Global Type 1 Diabetes (T1D) Consumption by Regions
      • 4.2 North America Type 1 Diabetes (T1D) Consumption (2014-2019)
      • 4.3 Europe Type 1 Diabetes (T1D) Consumption (2014-2019)
      • 4.4 China Type 1 Diabetes (T1D) Consumption (2014-2019)
      • 4.5 Japan Type 1 Diabetes (T1D) Consumption (2014-2019)

      5 Global Type 1 Diabetes (T1D) Production, Revenue, Price Trend by Type

      • 5.1 Global Type 1 Diabetes (T1D) Production Market Share by Type (2014-2019)
      • 5.2 Global Type 1 Diabetes (T1D) Revenue Market Share by Type (2014-2019)
      • 5.3 Global Type 1 Diabetes (T1D) Price by Type (2014-2019)
      • 5.4 Global Type 1 Diabetes (T1D) Production Growth by Type (2014-2019)

      6 Global Type 1 Diabetes (T1D) Market Analysis by Applications

      • 6.1 Global Type 1 Diabetes (T1D) Consumption Market Share by Application (2014-2019)
      • 6.2 Global Type 1 Diabetes (T1D) Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Type 1 Diabetes (T1D) Business

      • 7.1 Novo Nordisk
        • 7.1.1 Novo Nordisk Type 1 Diabetes (T1D) Production Sites and Area Served
        • 7.1.2 Type 1 Diabetes (T1D) Product Introduction, Application and Specification
        • 7.1.3 Novo Nordisk Type 1 Diabetes (T1D) Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 Sanofi
        • 7.2.1 Sanofi Type 1 Diabetes (T1D) Production Sites and Area Served
        • 7.2.2 Type 1 Diabetes (T1D) Product Introduction, Application and Specification
        • 7.2.3 Sanofi Type 1 Diabetes (T1D) Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Eli Lilly
        • 7.3.1 Eli Lilly Type 1 Diabetes (T1D) Production Sites and Area Served
        • 7.3.2 Type 1 Diabetes (T1D) Product Introduction, Application and Specification
        • 7.3.3 Eli Lilly Type 1 Diabetes (T1D) Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Merck
        • 7.4.1 Merck Type 1 Diabetes (T1D) Production Sites and Area Served
        • 7.4.2 Type 1 Diabetes (T1D) Product Introduction, Application and Specification
        • 7.4.3 Merck Type 1 Diabetes (T1D) Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 Boehringer Ingelheim
        • 7.5.1 Boehringer Ingelheim Type 1 Diabetes (T1D) Production Sites and Area Served
        • 7.5.2 Type 1 Diabetes (T1D) Product Introduction, Application and Specification
        • 7.5.3 Boehringer Ingelheim Type 1 Diabetes (T1D) Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 Samsung Bioepis
        • 7.6.1 Samsung Bioepis Type 1 Diabetes (T1D) Production Sites and Area Served
        • 7.6.2 Type 1 Diabetes (T1D) Product Introduction, Application and Specification
        • 7.6.3 Samsung Bioepis Type 1 Diabetes (T1D) Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 Biocon
        • 7.7.1 Biocon Type 1 Diabetes (T1D) Production Sites and Area Served
        • 7.7.2 Type 1 Diabetes (T1D) Product Introduction, Application and Specification
        • 7.7.3 Biocon Type 1 Diabetes (T1D) Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 Astellas
        • 7.8.1 Astellas Type 1 Diabetes (T1D) Production Sites and Area Served
        • 7.8.2 Type 1 Diabetes (T1D) Product Introduction, Application and Specification
        • 7.8.3 Astellas Type 1 Diabetes (T1D) Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served
      • 7.9 Janssen
        • 7.9.1 Janssen Type 1 Diabetes (T1D) Production Sites and Area Served
        • 7.9.2 Type 1 Diabetes (T1D) Product Introduction, Application and Specification
        • 7.9.3 Janssen Type 1 Diabetes (T1D) Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.9.4 Main Business and Markets Served
      • 7.10 Bristol-Myers Squibb
        • 7.10.1 Bristol-Myers Squibb Type 1 Diabetes (T1D) Production Sites and Area Served
        • 7.10.2 Type 1 Diabetes (T1D) Product Introduction, Application and Specification
        • 7.10.3 Bristol-Myers Squibb Type 1 Diabetes (T1D) Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.10.4 Main Business and Markets Served
      • 7.11 Lexicon
      • 7.12 Sanofi

      8 Type 1 Diabetes (T1D) Manufacturing Cost Analysis

      • 8.1 Type 1 Diabetes (T1D) Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Type 1 Diabetes (T1D)
      • 8.4 Type 1 Diabetes (T1D) Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Type 1 Diabetes (T1D) Distributors List
      • 9.3 Type 1 Diabetes (T1D) Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Type 1 Diabetes (T1D) Market Forecast

      • 11.1 Global Type 1 Diabetes (T1D) Production, Revenue Forecast
        • 11.1.1 Global Type 1 Diabetes (T1D) Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Type 1 Diabetes (T1D) Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Type 1 Diabetes (T1D) Price and Trend Forecast (2019-2025)
      • 11.2 Global Type 1 Diabetes (T1D) Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Type 1 Diabetes (T1D) Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Type 1 Diabetes (T1D) Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Type 1 Diabetes (T1D) Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Type 1 Diabetes (T1D) Production, Revenue Forecast (2019-2025)
      • 11.3 Global Type 1 Diabetes (T1D) Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Type 1 Diabetes (T1D) Consumption Forecast (2019-2025)
        • 11.3.2 Europe Type 1 Diabetes (T1D) Consumption Forecast (2019-2025)
        • 11.3.3 China Type 1 Diabetes (T1D) Consumption Forecast (2019-2025)
        • 11.3.4 Japan Type 1 Diabetes (T1D) Consumption Forecast (2019-2025)
      • 11.4 Global Type 1 Diabetes (T1D) Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Type 1 Diabetes (T1D) Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Summary:
        Get latest Market Research Reports on Type 1 Diabetes (T1D) . Industry analysis & Market Report on Type 1 Diabetes (T1D) is a syndicated market report, published as Global Type 1 Diabetes (T1D) Market Research Report 2019. It is complete Research Study and Industry Analysis of Type 1 Diabetes (T1D) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

        Last updated on

        REPORT YOU MIGHT BE INTERESTED

        Purchase this Report

        $2,900.00
        $4,350.00
        $5,800.00
        2,180.80
        3,271.20
        4,361.60
        2,598.40
        3,897.60
        5,196.80
        417,484.00
        626,226.00
        834,968.00
        242,353.00
        363,529.50
        484,706.00
        Credit card Logo

        Related Reports


        Reason to Buy

        Request for Sample of this report